LPL Financial
ROIV icon

LPL Financial’s Roivant Sciences ROIV Stock Holding History

LPL Financial’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Sell
334,376
-44,280
-12% -$1.31M ﹤0.01% 1980
2026
Q1 		$10.5M Buy
378,656
+27,189
+8% +$698K ﹤0.01% 1961
2025
Q4 		$7.63M Buy
351,467
+239,247
+213% +$4.72M ﹤0.01% 2172
2025
Q3 		$1.7M Buy
112,220
+74,890
+201% +$927K ﹤0.01% 3473
2025
Q2 		$421K Buy
37,330
+17,198
+85% +$186K ﹤0.01% 4519
2025
Q1 		$203K Sell
20,132
-53,176
-73% -$575K ﹤0.01% 4862
2024
Q4 		$867K Buy
73,308
+7,452
+11% +$88.1K ﹤0.01% 3614
2024
Q3 		$760K Buy
65,856
+35,378
+116% +$403K ﹤0.01% 3648
2024
Q2 		$322K Sell
30,478
-8,062
-21% -$88.3K ﹤0.01% 4211
2024
Q1 		$406K Buy
38,540
+18,550
+93% +$200K ﹤0.01% 3952
2023
Q4 		$224K Buy
19,990
+9,080
+83% +$88.5K ﹤0.01% 4307
2023
Q3 		$127K Buy
+10,910
New +$123K ﹤0.01% 4370

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

LPL Financial's ROIV Position: Q2 2026 in Review

LPL Financial reduced its Roivant Sciences (ROIV) stake by 12% in Q2 2026, selling an estimated $1.31M and leaving 334,376 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1980.

LPL Financial first reported a position in ROIV in Q3 2023 and has held it in 12 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • LPL Financial held 334,376 shares of Roivant Sciences worth $11.8M as of Q2 2026.
  • LPL Financial sold 44,280 Roivant Sciences shares in Q2 2026, an estimated $1.31M.
  • Roivant Sciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #1980 holding.
  • LPL Financial first reported a position in Roivant Sciences in Q3 2023 and has held it in 12 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.